Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha1-adrenoceptors in testosterone-induced prostatic hypertrophy

L Auger-Pourmarin1, P Roubert, P E Chabrier

  • 1Institute Henri Beaufour, Z.A. de Courtaboeuf, Les Ulis, France.

European Journal of Pharmacology
|March 7, 1998
PubMed
Summary

Testosterone-induced prostatic hypertrophy in rats did not alter alpha1-adrenoceptor mRNA levels. Overall alpha1-adrenoceptor density decreased, but this was attributed to changes in prostatic tissue composition, not direct receptor modification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.

Journal of medicinal chemistry·2001
Same author

Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5.

Bioorganic & medicinal chemistry letters·2001
Same author

BN 80933 inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures.

Neuroreport·2000
Same author

In vitro antioxidant neuroprotective activity of BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation.

Journal of neurochemistry·2000
Same author

BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy.

Proceedings of the National Academy of Sciences of the United States of America·1999
Same author

Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.

Cellular and molecular life sciences : CMLS·1999

Area of Science:

  • Pharmacology
  • Urology
  • Molecular Biology

Background:

  • Alpha1-adrenoceptors play a crucial role in regulating smooth muscle function, including in the prostate.
  • Prostatic hypertrophy is often associated with alterations in adrenoceptor expression and function.
  • Understanding adrenoceptor subtypes and their regulation is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the modifications of rat prostatic alpha1-adrenoceptors in the context of testosterone-induced prostatic hypertrophy.
  • To characterize the specific subtypes of alpha1-adrenoceptors present in the rat prostate and their binding properties.
  • To determine the effect of testosterone administration on both the density and mRNA levels of prostatic alpha1-adrenoceptors.

Main Methods:

Related Experiment Videos

  • Radioligand binding assays using [3H]prazosin to determine adrenoceptor density and affinity.
  • Pharmacological characterization of binding sites using selective ligands like chloroethylclonidine, oxymetazoline, and 5-methyl-urapidil.
  • Detection of mRNA for alpha1a, alpha1b, and alpha1d adrenoceptor subtypes using molecular biology techniques.

    • Main Results:

    • A single class of high-affinity [3H]prazosin binding sites was identified, with alpha1A-adrenoceptors constituting the majority.
    • Alpha1B-adrenoceptors were also identified as chloroethylclonidine-sensitive binding sites.
    • Testosterone administration led to a 23% decrease in alpha1-adrenoceptor density, primarily due to changes in prostatic tissue composition (increased epithelium, decreased smooth muscle).
    • Steady-state mRNA levels for all investigated alpha1-adrenoceptor subtypes remained unchanged following testosterone treatment.

    Conclusions:

    • Prostate alpha1-adrenoceptors, specifically their mRNA expression, are not directly affected by testosterone-induced prostatic hypertrophy.
    • The observed decrease in alpha1-adrenoceptor density is a consequence of altered prostatic tissue architecture rather than a direct impact on the receptors themselves.
    • These findings suggest that the functional consequences of prostatic hypertrophy may not be solely mediated by changes in alpha1-adrenoceptor expression levels.